Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

被引：0
|
作者：
Gilbert, D.
Kim, D.
Miller, M.
Horine, S.
Saljooqi, K.
Karkanias, G.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
149
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [21] ELAMIPRETIDE IN THE MMPOWER-2 OPEN-LABEL EXTENSION TRIAL (OLE): LONG-TERM SAFETY AND TOLERABILITY
    Karaa, Amel
    Haas, Richard
    Goldstein, Amy
    Vockley, Gerard
    Cohen, Bruce
    MUSCLE & NERVE, 2018, 58 : S34 - S34
  • [22] Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
    Partinen, Markku
    Hirvonen, Kari
    Jama, Leni
    Alakuijala, Anniina
    Hublin, Christer
    Tamminen, Ilkka
    Koester, Juergen
    Reess, Juergen
    SLEEP MEDICINE, 2008, 9 (05) : 537 - 541
  • [23] Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS) in an Open-Label Extension (OLE) Trial
    Shiloh-Malawsky, Y.
    Scheffer, I
    Halford, J.
    Nabbout, R.
    Sanchez-Carpintero, R.
    Wong, M.
    Checketts, D.
    VanLandingham, K.
    ANNALS OF NEUROLOGY, 2019, 86 : S71 - S72
  • [24] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [25] Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study (vol 20, pg 49, 2021)
    Adams, D.
    Polydefkis, M.
    Gonzalez-Duarte, A.
    LANCET NEUROLOGY, 2021, 20 (02): : E2 - E2
  • [26] Long-term Safety and Efficacy of Cannabidiol (CBD) in Patients with Lennox-Gastaut Syndrome (LGS): Results of the Open-label Extension (OLE) Trial (GWPCARE5)
    Thiele, E.
    Marsh, E.
    Halford, J.
    Mazurkiewicz-Beldzinska, M.
    Gunning, B.
    Checketts, D.
    Roberts, C.
    ANNALS OF NEUROLOGY, 2018, 84 : S336 - S336
  • [27] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Ivy, Dunbar
    Beghetti, Maurice
    Juaneda-Simian, Ernesto
    Ravindranath, Ramiya
    Lukas, Mary Ann
    Machlitt-Northen, Sandra
    Scott, Nicola
    Narita, Jun
    Berger, Rolf M. F.
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2123 - 2130
  • [28] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Dunbar Ivy
    Maurice Beghetti
    Ernesto Juaneda-Simian
    Ramiya Ravindranath
    Mary Ann Lukas
    Sandra Machlitt-Northen
    Nicola Scott
    Jun Narita
    Rolf M. F. Berger
    European Journal of Pediatrics, 2024, 183 : 2141 - 2153
  • [29] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [30] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
12345